| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |